KR20230131182A - 진통 효과를 유도하기 위한 디카르복실산 에스테르 - Google Patents

진통 효과를 유도하기 위한 디카르복실산 에스테르 Download PDF

Info

Publication number
KR20230131182A
KR20230131182A KR1020237020625A KR20237020625A KR20230131182A KR 20230131182 A KR20230131182 A KR 20230131182A KR 1020237020625 A KR1020237020625 A KR 1020237020625A KR 20237020625 A KR20237020625 A KR 20237020625A KR 20230131182 A KR20230131182 A KR 20230131182A
Authority
KR
South Korea
Prior art keywords
pain
subject
weight
acid ester
dicarboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237020625A
Other languages
English (en)
Korean (ko)
Inventor
로버트 티. 스트리퍼
엘즈비에타 이지비카
Original Assignee
뉴 프런티어 랩스 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 뉴 프런티어 랩스 엘엘씨 filed Critical 뉴 프런티어 랩스 엘엘씨
Publication of KR20230131182A publication Critical patent/KR20230131182A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1020237020625A 2020-12-16 2021-12-16 진통 효과를 유도하기 위한 디카르복실산 에스테르 Pending KR20230131182A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063126387P 2020-12-16 2020-12-16
US63/126,387 2020-12-16
PCT/IB2021/061872 WO2022130288A1 (en) 2020-12-16 2021-12-16 Dicarboxylic acid esters for inducing an analgesic effect

Publications (1)

Publication Number Publication Date
KR20230131182A true KR20230131182A (ko) 2023-09-12

Family

ID=81942874

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237020625A Pending KR20230131182A (ko) 2020-12-16 2021-12-16 진통 효과를 유도하기 위한 디카르복실산 에스테르

Country Status (12)

Country Link
US (1) US11911358B2 (enExample)
EP (1) EP4262779A4 (enExample)
JP (1) JP7837335B2 (enExample)
KR (1) KR20230131182A (enExample)
CN (1) CN116829141A (enExample)
AU (1) AU2021400215A1 (enExample)
CA (1) CA3202461A1 (enExample)
CL (1) CL2023001737A1 (enExample)
CO (1) CO2023007903A2 (enExample)
IL (1) IL303751A (enExample)
MX (1) MX2023006728A (enExample)
WO (1) WO2022130288A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112022022437A2 (pt) 2020-05-07 2023-01-03 Adorx Therapeutics Ltd Antagonistas do receptor a2a de adenosina
US20260048034A1 (en) 2024-08-15 2026-02-19 New Frontier Labs, Llc Compositions and methods for enhancing the efficacy of dicarboxylic acid esters, and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS539788A (en) * 1976-07-14 1978-01-28 Syntex Inc 55aloyll1*22dihydroo3hh pyroro *1*22a* pyroll11 carboxylic acid derivative
JPH07116026B2 (ja) * 1987-07-07 1995-12-13 株式会社資生堂 ジクロフェナックナトリウム含有乳化外用剤
JP2523428B2 (ja) * 1992-12-04 1996-08-07 エスエス製薬株式会社 消炎鎮痛ゲル製剤
US9265725B2 (en) * 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
JP2004300113A (ja) * 2003-04-01 2004-10-28 Nichiban Co Ltd 消炎鎮痛貼付剤
WO2006074379A2 (en) * 2005-01-07 2006-07-13 Azaya Therapeutics, Inc. Methods and compositions involving esters of azelaic acid and other dicarboxylic acids
US8822509B2 (en) * 2006-12-29 2014-09-02 The University Of Queensland Pain-relieving compositions and uses therefor
EP2219633A2 (en) * 2007-11-23 2010-08-25 Nectid, Inc. Tapentadol compositions
US20090326069A1 (en) * 2008-06-30 2009-12-31 Bltn, Llc Azelaic acid ester compositions and methods for diagnosing and treating tissue conditions using azelaic acid ester compositions and proteinaceous biomarkers
BRPI0901758A2 (pt) * 2009-05-28 2011-01-25 Cristalia Prod Quimicos Farm uso de telocinobufagina como analgésico no tratamento das dores aguda e crÈnica; composição farmacêutica contendo telocinobufagina e uso da mesma
US20120251525A1 (en) * 2009-06-30 2012-10-04 Streeper Robert T Method of utilizing azelaic acid esters to modulate communications mediated by biological molecules
EP3445354B8 (en) * 2016-04-20 2022-07-06 New Frontier Labs, LLC Azelaic acid esters in the treatment of insulin resistance
US20220023423A1 (en) * 2018-12-19 2022-01-27 Medrx Co., Ltd. Anti-Inflammatory Analgesic External Preparation
CN111544381B (zh) * 2020-05-12 2021-07-16 普霖贝利生物医药研发(上海)有限公司 一种包含壬二酸的皮肤局部给药组合物

Also Published As

Publication number Publication date
AU2021400215A9 (en) 2025-03-20
CN116829141A (zh) 2023-09-29
MX2023006728A (es) 2023-06-19
WO2022130288A1 (en) 2022-06-23
EP4262779A4 (en) 2024-11-13
US11911358B2 (en) 2024-02-27
CA3202461A1 (en) 2022-06-23
AU2021400215A1 (en) 2023-07-06
US20220184023A1 (en) 2022-06-16
IL303751A (en) 2023-08-01
CO2023007903A2 (es) 2023-06-30
CL2023001737A1 (es) 2024-01-19
JP2023553642A (ja) 2023-12-25
EP4262779A1 (en) 2023-10-25
JP7837335B2 (ja) 2026-03-30

Similar Documents

Publication Publication Date Title
KR101478728B1 (ko) 안과 및 수의 안과에서 사용하기 위한 약학적 조성물
KR102014883B1 (ko) 근위축성 측삭 경화증 치료용 신규 조성물
KR101534422B1 (ko) 귀 질환 치료를 위한 제어 방출형 코르티코스테로이드 조성물 및 방법
RU2586289C1 (ru) Терапевтический или профилактический агент от дисфункции мейбомиевых желез или блокады мейбомиевых желез
WO2020068986A1 (en) Formulations for treatment of dry eye disease
ES2830447T3 (es) Método para la prevención y/o el tratamiento del deterioro cognitivo asociado al envejecimiento y la neuroinflamación
CN102573831A (zh) 用于治疗免疫相关病症的去铁胺-金属络合物
BR112020026989A2 (pt) Novas pequenas moléculas de imunomodulação
US11911358B2 (en) Dicarboxylic acid esters for inducing an analgesic effect
US20240382512A1 (en) Treatment of Immune-Related Disorders, Kidney Disorders, Liver Disorders, Hemolytic Disorders, and Oxidative Stress-Associated Disorders Using NRH, NARH and Reduced Derivatives Thereof
KR20190053215A (ko) 약물 전달을 위한 침투 증진제를 함유하는 조성물
JP2019530729A (ja) 緑内障の治療のための、リポソームによって担持されるシチコリンを含む眼科用処方
RU2542449C2 (ru) Композиции и способы лечения рака мочевого пузыря
AU2023201743A1 (en) Compositions and methods for inducing apoptosis in anaerobic cells and related clinical methods for treating cancer and pathogenic infections
Sanders et al. Aqueous penetration of oral and topical indomethacin in humans
CN105163732B (zh) 用于治疗眼科疾病和病症的方法
ES2729208T3 (es) Terapia basada en baclofeno y acamprosato de trastornos de degeneración macular
OA21266A (en) Dicarboxylic acid esters for inducing an analgesic effect.
US20260048034A1 (en) Compositions and methods for enhancing the efficacy of dicarboxylic acid esters, and uses thereof
RU2362554C2 (ru) Регенерирующее противовоспалительное средство и способы лечения с помощью этого средства
TWI382839B (zh) 控制釋放之皮質類固醇組成物及其用於耳部失調治療的方法
TW202523286A (zh) 立汎黴素（ｒｉｆａｍｙｃｉｎ）的眼用組成物及其用途
JP2025068006A (ja) ４－アミノフェノールの誘導体を増強することのための組成物及び方法
US20220072016A1 (en) Miltefosine for the treatment of viral infections including covid-19
CN105267215A (zh) 一种用于严重烧伤治疗的免疫调节剂

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R18 Changes to party contact information recorded

Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R18-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000